Study guide

3.2 Records, Labs, Allergies & Consent

Registered Cardiovascular Invasive Specialist RCIS

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current RCIS Exam Facts 1.2 Eligibility Pathways & Documentation 1.3 Examination Matrix & Study Plan

2 Pre-Procedural Room Setup & Sterile Technique

2.1 Procedure & Control Room Setup 2.2 Sterile Technique & Universal Precautions 2.3 Personnel Preparation & Cath Lab Roles

3 Pre-Procedural Patient Preparation & Validation

3.1 Preparing the Patient for Invasive Procedures 3.2 Records, Labs, Allergies & Consent 3.3 Time-Out & Universal Protocol

4 Patient Monitoring & Vascular Access

4.1 Intraprocedural Vital Sign Monitoring 4.2 Arterial & Venous Access Sites 4.3 Ultrasound-Guided Access

5 Coronary Anatomy & Left Heart Catheterization

5.1 Coronary Anatomy & Dominance 5.2 Left Heart Catheterization & Coronary Angiography 5.3 Catheter Shapes & Angiographic Projections 5.4 Left Ventriculography & Aortography

6 Right Heart Catheterization & Hemodynamics

6.1 Right Heart Waveforms & Pressures 6.2 Cardiac Output: Fick & Thermodilution 6.3 Valve Area, Bernoulli & Shunt Calculations 6.4 Endomyocardial Biopsy Support

7 ECG & Intracardiac/Intravascular Imaging

7.1 12-Lead ECG in the Cath Lab 7.2 Intracardiac Echocardiography (ICE) 7.3 IVUS & OCT 7.4 Identifying Structures on Cardiac Ultrasound

8 Physiology Assessment & Radiation Safety

8.1 FFR & iFR Studies 8.2 Radiation Safety & ALARA 8.3 Radiographic Equipment Operation 8.4 Image Acquisition & Interpretation

9 Cath Lab Pharmacology

9.1 Anticipating Pharmacologic Needs 9.2 Recognizing Medication Effects & Adverse Reactions 9.3 Anticoagulation & ACT Targets

10 PCI Fundamentals

10.1 Balloon Angioplasty & Stent Platforms 10.2 Coronary Wiring, Lesion Prep & Flow Grades 10.3 Vascular Closure Devices

11 Chapter 11: Complex Coronary Intervention

11.1 CTO, Atherectomy & Alcohol Septal Ablation 11.2 Cardiac Thrombectomy (Mechanical & Aspiration) 11.3 Distal Protection Devices

12 Device Implants & Temporary Support

12.1 Pacemaker, ICD, CRT & Loop Recorders 12.2 Transvenous Temporary Pacemaker 12.3 Pericardiocentesis Support

13 Mechanical Circulatory Support

13.1 IABP & Impella 13.2 ECMO & LVAD Overview for the Cath Lab

14 Peripheral Vascular Interventions

14.1 Peripheral Interventions 14.2 Complex Peripheral Interventions 14.3 Peripheral Thrombectomy & Thrombolysis

15 Structural Heart Interventions

15.1 Nonvalvular Structural Therapies 15.2 Percutaneous Valve Interventions

16 Chapter 16: Emergency Clinical Presentations & Equipment

16.1 STEMI, Cardiogenic Shock & Pulmonary Edema 16.2 Stroke & Neurologic Emergencies in the Lab 16.3 Emergency Equipment Operation

17 Intraprocedural Complications

17.1 Coronary Interventional Complications 17.2 Peripheral & Structural Complications

18 Post-Procedural Activities

18.1 Arterial & Venous Hemostasis 18.2 Access-Site Complications 18.3 Patient Education, Reporting & Transfer of Care

3.2 Records, Labs, Allergies & Consent

Key Takeaways Explain This Topic AI

Review the medical record for indication, prior cath reports, medication list, and allergy documentation before every invasive case — missing antiplatelet or anticoagulant data is a leading cause of preventable bleeding complications.

Creatinine with eGFR, coagulation studies, CBC, and pregnancy testing when indicated must be current per facility policy; the RCIS role includes recognizing which values require physician notification before contrast or access.

Valid informed consent and verified NPO status are legal and safety prerequisites; proceed only when consent is signed, allergies are communicated to the team, and NPO guidelines are met or an exception is documented.

Last updated: July 2026

Quick Answer: Before invasive cath lab procedures, validate the chart: confirm indication and prior studies, review allergies (especially contrast, iodine, latex, and drug reactions), verify current labs including renal function and coagulation, assess antiplatelet/anticoagulant timing, confirm NPO status, and ensure informed consent is signed and matches the planned procedure.

Record and laboratory validation is not clerical busywork — it is the last structured checkpoint before the patient enters the sterile field. RCIS Domain A Task 3 tests whether you know which data matter , what abnormal values imply , and when to halt the case until the physician resolves an issue.

Medical Record Review

Systematically review these chart elements:

  • Record Element Why It Matters
  • Procedure order / indication Confirms the correct study (diagnostic vs PCI vs structural)
  • History & physical / admission note Baseline status, comorbidities, recent events
  • Prior cath / PCI reports Anatomy, stent locations, prior access complications
  • Medication list Antiplatelets, anticoagulants, metformin, diuretics, insulin
  • Allergy list Contrast, iodine, latex, chlorhexidine, antibiotics, aspirin
  • Consent form Signed, dated, procedure named, risks discussed
  • Nursing pre-procedure checklist IV, labs drawn, NPO verified, pregnancy status

Compare the scheduled procedure to the consent document. A consent for "left heart catheterization" does not cover PCI unless addendum or separate consent exists per institutional policy.

Complete Blood Count (CBC)

  • Component Typical Relevance in Cath Lab
  • Hemoglobin / Hematocrit Identifies anemia; severe anemia may warrant transfusion planning before complex cases

Platelet count Thrombocytopenia increases bleeding risk at access and after closure devices; very low counts may delay procedure

WBC Markedly elevated WBC with fever may suggest active infection requiring delay

There is no universal platelet cutoff — institutions and operators vary — but platelets below approximately 50,000/µL commonly trigger physician consultation, and counts below 20,000/µL are generally prohibitive for invasive arterial work without hematology input. Know your facility threshold for exam scenarios.

Basic Metabolic Panel (BMP)

Electrolyte and metabolic abnormalities can precipitate arrhythmias during catheter manipulation and contrast administration:

  • BMP Component Pre-Procedure Concern
  • Potassium Hypokalemia and hyperkalemia both increase arrhythmia risk; critical values require correction
  • Sodium Severe hyponatremia affects neurologic status and fluid management
  • Glucose Hypoglycemia in NPO diabetics; hyperglycemia in poorly controlled diabetes
  • BUN / Creatinine Baseline renal function for contrast risk stratification (see below)
  • Coagulation Studies
  • Test Primary Use in Cath Lab
  • PT / INR Warfarin effect; elevated INR increases access-site and retroperitoneal bleeding risk
  • aPTT Unfractionated heparin effect; relevant when heparin drip recently discontinued
  • ACT (bedside) Baseline before procedural heparin; used for intraprocedural anticoagulation monitoring

Oral anticoagulant management varies by procedure urgency and bleeding risk. For elective diagnostic cath, many centers target INR ≤ 1.5–1.7 or hold warfarin with bridging per protocol. For PCI, anticoagulation strategy is operator-specific. The RCIS technologist reports values and confirms last dose timing — the physician decides whether to proceed, bridge, or reverse.

Antiplatelet and Anticoagulant Status

Accurate medication reconciliation prevents catastrophic bleeding and stent thrombosis:

  • Medication Class Pre-Procedure Considerations
  • Aspirin Usually continued for PCI; know if patient is aspirin-allergic

P2Y12 inhibitors (clopidogrel, ticagrelor, prasugrel) Elective cases may require hold periods; acute PCI typically requires loading — know institutional hold guidelines

  • GPIIb/IIIa inhibitors Short-acting; recent infusion affects bleeding risk
  • Warfarin / DOACs Hold intervals depend on drug, renal function, and procedure type
  • UFH / LMWH Recent doses affect aPTT and bleeding; reversal agents must be available

Document last dose date and time on the pre-procedure checklist. When a patient arrives on dual antiplatelet therapy for recent stent placement, stopping therapy for an elective procedure may be contraindicated — flag this to the physician immediately.

Creatinine, eGFR, and Contrast Risk

Iodinated contrast is nephrotoxic, especially in patients with chronic kidney disease (CKD) , diabetes, heart failure, or hypovolemia. Calculate or verify estimated GFR (eGFR) from serum creatinine, age, sex, and race/ethnicity per the lab report.

  • eGFR (mL/min/1.73 m²) General Risk Stratification
  • ≥ 60 Lower risk; standard hydration often sufficient
  • 30–59 (CKD Stage 3) Moderate risk; hydration protocols, minimize contrast volume
  • 15–29 (CKD Stage 4) High risk; nephrology consultation often considered
  • < 15 or dialysis Very high risk; contrast use requires careful risk-benefit decision

Additional risk reducers the team may employ: hold metformin 48 hours post-contrast (per facility policy to reduce lactic acidosis concern), IV isotonic hydration before and after, use lowest adequate contrast volume, and consider alternative imaging when eGFR is severely reduced.

Report acute creatinine rise compared to prior baseline — this may indicate acute kidney injury and warrants physician review even if absolute value seems acceptable.

Pregnancy Testing

Ionizing radiation and contrast expose the fetus to risk. For women of childbearing potential , verify pregnancy status within the institution's required window (commonly 24–72 hours or day-of test per policy) before any fluoroscopy case. A negative urine or serum hCG must be documented unless the case is a true emergency and testing is impossible — and even then, the team minimizes exposure.

NPO (Nothing by Mouth) Status

NPO guidelines reduce aspiration risk during moderate sedation and emergencies:

  • Intake Typical Minimum Fast (Elective Cases)*
  • Clear liquids 2 hours
  • Light meal / non-clear liquids 6 hours
  • Heavy / fatty meal 8 hours or longer

*Always follow your institution's and anesthesia department's policy — exam questions usually reflect ASA-style guidelines.

Clear liquids include water, pulp-free juice, black coffee, and tea without milk. Not clear: milk, formula, alcoholic beverages, particulate juices. Chewing gum and hard candy may violate NPO at some centers — confirm policy.

If a patient ate recently, the case is typically delayed unless it is a life-threatening emergency (e.g., STEMI primary PCI), where aspiration risk is weighed against mortality benefit.

Allergy Verification

Never rely on verbal report alone — read the allergy list in the chart and ask the patient to confirm. High-yield cath lab allergies:

Allergen Implication

Iodinated contrast / iodine / shellfish Not a true cross-reactivity in most patients, but flags contrast reaction history; premedication protocol may apply

  • Latex Use latex-free gloves, drapes, tourniquets
  • Chlorhexidine Alternative skin prep required
  • Aspirin / NSAIDs / P2Y12 drugs Affects pre-medication and stent pharmacotherapy planning
  • Heparin (HIT history) Alternative anticoagulation required

Communicate allergies aloud during team briefings and ensure armband/allergy band is visible.

Informed Consent

Valid consent requires the performing physician (or delegated provider per state law) to explain:

Nature of the procedure and alternatives

Material risks: bleeding, vascular injury, contrast reaction, kidney injury, stroke (for certain procedures), radiation exposure, need for emergent surgery or transfusion

Benefits and consequences of refusal

The RCIS technologist verifies consent is signed, witnessed per policy, and matches the scheduled procedure before scrubbing. If the patient has new questions or appears uncertain, pause and notify the physician — do not pressure the patient to proceed.

Emergent cases may proceed under implied consent when the patient cannot participate and delay would cause harm; document circumstances thoroughly.

Putting Validation Together: A Pre-Procedure Matrix

  • Checkpoint Pass Fail Action
  • Consent signed for planned procedure Proceed to time-out Obtain/ amend consent
  • Allergies reviewed with team Proceed Implement precautions
  • NPO verified Proceed Delay or document emergency exception
  • Creatinine/eGFR acceptable or risk mitigated Proceed Physician consult, hydration, minimize contrast
  • Coagulation acceptable for planned access Proceed Hold/reverse per physician order
  • Antiplatelet plan confirmed Proceed Clarify before arterial sheath insertion
  • Pregnancy status verified (if applicable) Proceed Test before fluoroscopy

When any checkpoint fails, the RCIS role is to communicate clearly and stop the line until the physician resolves the issue. Validation complete means the team can enter the time-out with confidence that hidden landmines — unchecked INR, undocumented contrast allergy, or missing consent — have been cleared.